FLEMINGTON, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations of a broad range of marketed treatments, today announced results for the five month transition period ended December 31, 2006. As previously reported, NovaDel has changed its fiscal year-end from July 31 to December 31, effective as of December 31, 2006.
